ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

New Jersey Legislature Votes to Oppose USPSTF PSA Screening Downgrade

January 20, 2012

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

March 23, 2007

In Brief: NCI Registers Web Domain CANCER>GOV, Plans To Improve External Communications

October 29, 1999

Duke wins Avon-NCI funding.

October 31, 2003

Budget Cut Asked By Ford Would Hold Grant Funding To 20%

January 10, 1975

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

April 8, 2005